Johnson & Johnson to Appeal Flawed Opioid Judgment in Oklahoma
August 26, 2019
August 26, 2019
NEW BRUNSWICK, New Jersey, Aug. 26 -- Johnson and Johnson issued the following news release:
* * *
- Company Did Not Cause Opioid Crisis; Neither Facts Nor Law Support This Outcome
- Company Confident It Has Strong Grounds For Appeal
* * *
Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceutical Companies today announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State . . .
* * *
- Company Did Not Cause Opioid Crisis; Neither Facts Nor Law Support This Outcome
- Company Confident It Has Strong Grounds For Appeal
* * *
Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceutical Companies today announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State . . .